For example, models combining Nf1 and Trp53 deletions have been instrumental in studying malignant peripheral nerve sheath tumours (MPNSTs), revealing the interplay of these mutations in tumour progression and response to therapy [118]. This evidence concerns the gene NF1 and neoplasm.